Double cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment

scientific article

Double cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00320015
P698PubMed publication ID3128351

P2093author name stringJ Marrink
P C Das
C T Smit Sibinga
J vd Meer
J Notebomer
P J Schulting
P2860cites workIn vivo effectiveness of a high-yield factor VIII concentrate prepared in a blood bankQ33462009
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factorQ34550838
Interactions among Heparin, Cold-Insoluble Globulin, and Fibrinogen in Formation of the Heparin-Precipitable Fraction of PlasmaQ37047470
Fibronectin in blood products--an in vitro and in vivo studyQ37177156
Biometric principles in clotting and clot lysis assaysQ40292819
Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia AQ40667948
Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.Q44284339
Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiationQ45834057
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet lightQ45840287
High-yield method of production of freeze-dried purified factor VIII by blood banksQ45861062
In vitro and in vivo characterization of factor VIII preparationsQ45863709
Case for concluding that heat-treated, licensed anti-haemophilic factor is free from HTLV-III.Q45885231
The presence of high and low molecular weight forms of factor VIII in heparinized plasmaQ47317587
Inactivation by wet and dry heat of AIDS-associated retroviruses during factor VIII purification from plasmaQ69864992
Wet heating for safer factor VIII concentrate?Q69869220
Fibronectin-complex (FN-C) present in normal plasmaQ70098530
Heparin small pool high yield purified factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrateQ70477511
Observations on the heterogeneity of fibronectin CQ71311563
In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparationsQ71513494
Factor VIII related antigen: an improved enzyme immunoassayQ71635554
Factor VIII standardisationQ72541988
A quick and accurate method for the determination of fibronogen in plasmaQ78934157
P433issue3
P304page(s)111-116
P577publication date1988-03-01
P1433published inBlutQ27709414
P1476titleDouble cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment
P478volume56